Theravance Biopharma, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-4.46 | $-5.79 |
| FY2021 | $-2.87 | $-5.55 |
| FY2022 | $11.85 | $-4.23 |
| FY2023 | $-1.00 | $-3.68 |
| FY2024 | $-1.15 | $-2.80 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-4.46 | $-5.79 |
| FY2021 | $-2.87 | $-5.55 |
| FY2022 | $11.85 | $-4.23 |
| FY2023 | $-1.00 | $-3.68 |
| FY2024 | $-1.15 | $-2.80 |